Eledon Pharmaceuticals (ELDN) EPS (Basic) Growth (3y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 139.68% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 25.99% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 41.58% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 14.28% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 58.35% |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -2.92% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 45.92% |
| 10 | Eledon Pharmaceuticals | 419.90 Mn | 203.87 Mn | - | 23.94% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 23.94% |
| Dec 31, 2025 | 64.05% |
| Sep 30, 2025 | 33.99% |
| Jun 30, 2025 | 41.52% |
| Mar 31, 2025 | 51.24% |
| Dec 31, 2024 | -9.60% |
| Sep 30, 2024 | 53.13% |
| Jun 30, 2024 | -28.46% |
| Mar 31, 2024 | -298.68% |
| Dec 31, 2023 | -64.20% |
| Sep 30, 2023 | 60.88% |
| Jun 30, 2023 | 0.00% |
| Mar 31, 2023 | 55.52% |
| Dec 31, 2022 | 10.37% |
| Sep 30, 2022 | 43.32% |
| Jun 30, 2022 | -22.92% |
| Mar 31, 2022 | -9.89% |
| Dec 31, 2021 | -6.98% |
| Sep 30, 2021 | -21.28% |
| Jun 30, 2021 | -13.72% |
| Mar 31, 2021 | -16.55% |
| Dec 31, 2020 | 187.65% |
| Sep 30, 2020 | -134.01% |
| Jun 30, 2020 | -27.56% |
| Mar 31, 2020 | -143.52% |
| Dec 31, 2019 | -222.08% |
| Sep 30, 2019 | 2.68% |
| Jun 30, 2019 | 46.22% |
| Mar 31, 2019 | -0.65% |
| Dec 31, 2018 | 0.00% |
| Sep 30, 2018 | 11.29% |
| Jun 30, 2018 | 5.27% |
| Mar 31, 2018 | 15.18% |
| Dec 31, 2017 | 43.69% |
| Sep 30, 2017 | 45.86% |
| Jun 30, 2017 | 51.65% |
| Mar 31, 2017 | 60.79% |
| Dec 31, 2016 | 75.26% |
| Sep 30, 2016 | 13.92% |